Medicxi Launches Alys Pharmaceuticals in $100m Seed Funding by Mark Eisenberg 19.02.2024 Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
Connect Biopharma Welcomes James Huang: Growth Surge Ahead by Mark Eisenberg 13.02.2024 Connect Biopharma has appointed James Zuie-chin Huang to its Board of Directors. Huang brings over 30 years of biotech experience ...